Genetics of Valvular Heart Disease

Valvular heart disease is associated with significant morbidity and mortality and often the result of congenital malformations. However, the prevalence is increasing in adults not only because of the growing aging population, but also because of improvements in the medical and surgical care of children with congenital heart valve defects. The success of the Human Genome Project and major advances in genetic technologies, in combination with our increased understanding of heart valve development, has led to the discovery of numerous genetic contributors to heart valve disease. These have been uncovered using a variety of approaches including the examination of familial valve disease and genome-wide association studies to investigate sporadic cases. This review will discuss these findings and their implications in the treatment of valvular heart disease.

[1]  S. Hokari,et al.  Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: Roles of transforming growth factor (TGF)‐β and bone morphogenetic protein (BMP) , 2000, The Anatomical record.

[2]  R. Hinton,et al.  Heart valve structure and function in development and disease. , 2011, Annual review of physiology.

[3]  B. Keavney,et al.  Nonsynonymous variants in the SMAD6 gene predispose to congenital cardiovascular malformation , 2012, Human mutation.

[4]  R. Kist,et al.  Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development. , 2007, Developmental biology.

[5]  L. Garavelli,et al.  Clinical and molecular characterization of 40 patients with classic Ehlers–Danlos syndrome: identification of 18 COL5A1 and 2 COL5A2 novel mutations , 2013, Orphanet Journal of Rare Diseases.

[6]  D. Srivastava,et al.  Mutations in NOTCH1 cause aortic valve disease , 2005, Nature.

[7]  Raymond B. Runyan,et al.  Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart. , 1999, Science.

[8]  J. Trochu,et al.  Mutations in the Gene Encoding Filamin A as a Cause for Familial Cardiac Valvular Dystrophy , 2006, Circulation.

[9]  V. Garg,et al.  Insights into the genetic basis of congenital heart disease , 2006, Cellular and Molecular Life Sciences CMLS.

[10]  K. Yutzey,et al.  Ras-related signaling pathways in valve development: ebb and flow. , 2005, Physiology.

[11]  S. Fisher,et al.  Identification of RNA binding motif proteins essential for cardiovascular development , 2011, BMC Developmental Biology.

[12]  B. Gelb,et al.  Noonan syndrome and clinically related disorders. , 2011, Best practice & research. Clinical endocrinology & metabolism.

[13]  S. Cross,et al.  Cardiac malformations and midline skeletal defects in mice lacking filamin A. , 2006, Human molecular genetics.

[14]  Genetic evidence that mutations in the COL1A1, COL1A2, COL3A1, or COL5A2 collagen genes are not responsible for mitral valve prolapse. , 1989, British heart journal.

[15]  B. Funke,et al.  Familial ebstein anomaly, left ventricular hypertrabeculation, and ventricular septal defect associated with a MYH7 mutation , 2013, American journal of medical genetics. Part A.

[16]  P. Libby,et al.  Activated Interstitial Myofibroblasts Express Catabolic Enzymes and Mediate Matrix Remodeling in Myxomatous Heart Valves , 2001, Circulation.

[17]  A. G. Gittenberger-de Groot,et al.  Epicardium-derived cells contribute a novel population to the myocardial wall and the atrioventricular cushions. , 1998, Circulation research.

[18]  M. Fishman,et al.  Fashioning the vertebrate heart: earliest embryonic decisions. , 1997, Development.

[19]  Bruce D Gelb,et al.  Noonan syndrome and related disorders: genetics and pathogenesis. , 2005, Annual review of genomics and human genetics.

[20]  R. Hinton,et al.  Insufficient versican cleavage and Smad2 phosphorylation results in bicuspid aortic and pulmonary valves. , 2013, Journal of molecular and cellular cardiology.

[21]  Robert H. Anderson,et al.  Genetically alike Syrian hamsters display both bifoliate and trifoliate aortic valves , 2012, Journal of anatomy.

[22]  D. Srivastava,et al.  Congenital Heart Disease–Causing Gata4 Mutation Displays Functional Deficits In Vivo , 2012, PLoS genetics.

[23]  R. Wenstrup,et al.  Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type , 2010, Genetics in Medicine.

[24]  Bin Zhou,et al.  Nfatc1 Coordinates Valve Endocardial Cell Lineage Development Required for Heart Valve Formation , 2011, Circulation research.

[25]  A. Tongut,et al.  Pulmonary stenosis as a predisposing factor for infective endocarditis in a patient with Noonan syndrome. , 2010, Texas Heart Institute journal.

[26]  G. Andelfinger,et al.  Loss of Gata5 in mice leads to bicuspid aortic valve. , 2011, The Journal of clinical investigation.

[27]  R. Glanville,et al.  Partial sequence of a candidate gene for the Marfan syndrome , 1991, Nature.

[28]  V. Garg.  Molecular Basis of Cardiac Development and Congenital Heart Disease , 2012 .

[29]  Y. Matsubara,et al.  The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders , 2008, Human mutation.

[30]  D. Arking,et al.  Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. , 2003, Nature genetics.

[31]  D. Stewart,et al.  Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. , 2000, Circulation.

[32]  D. Srivastava,et al.  Notch1 represses osteogenic pathways in aortic valve cells. , 2009, Journal of molecular and cellular cardiology.

[33]  K. Yutzey,et al.  Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development. , 2006, Developmental biology.

[34]  S. Verma,et al.  Clinical and Pathophysiological Implications of a Bicuspid Aortic Valve , 2002, Circulation.

[35]  N. Niikawa,et al.  A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family , 2004, Journal of Medical Genetics.

[36]  N. Trehan,et al.  Valvular heart disease: diagnosis and management. , 2007, The Journal of the Association of Physicians of India.

[37]  D. C. Miller,et al.  Valvular Heart Disease in Patients with Osteogenesis Imperfecta , 2013, Journal of cardiac surgery.

[38]  C. Semsarian,et al.  Management of the ascending aorta in patients with bicuspid aortic valve disease. , 2008, Heart, lung & circulation.

[39]  C. Yeh,et al.  Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease. , 2009, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[40]  K. Yutzey,et al.  Heart Valve Development: Regulatory Networks in Development and Disease , 2009, Circulation research.

[41]  M. Andreassi,et al.  Sequencing of NOTCH1, GATA5, TGFBR1 and TGFBR2 genes in familial cases of bicuspid aortic valve , 2013, BMC Medical Genetics.

[42]  D. Gilliland,et al.  Mouse model of Noonan syndrome reveals cell type– and gene dosage–dependent effects of Ptpn11 mutation , 2004, Nature Medicine.

[43]  B. Neel,et al.  Noonan syndrome cardiac defects are caused by PTPN11 acting in endocardium to enhance endocardial-mesenchymal transformation , 2009, Proceedings of the National Academy of Sciences.

[44]  K. Xia,et al.  A novel mutation of GATA4 (K319E) is responsible for familial atrial septal defect and pulmonary valve stenosis. , 2014, Gene.

[45]  G. Thiene,et al.  Bicuspid aortic and pulmonary valves in the Syrian hamster. , 1992, International journal of cardiology.

[46]  D. Menick,et al.  Reduced versican cleavage due to Adamts9 haploinsufficiency is associated with cardiac and aortic anomalies. , 2010, Matrix biology : journal of the International Society for Matrix Biology.

[47]  Elaine L. Lee,et al.  Abundance and location of proteoglycans and hyaluronan within normal and myxomatous mitral valves. , 2009, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[48]  J. Opitz,et al.  Prevalence of mitral-valve prolapse in the Stickler syndrome. , 1986, American journal of medical genetics.

[49]  Robert H. Anderson,et al.  Expression of the BMP Receptor Alk3 in the Second Heart Field Is Essential for Development of the Dorsal Mesenchymal Protrusion and Atrioventricular Septation , 2013, Circulation research.

[50]  H. Garner,et al.  Inhibitory Role of Notch1 in Calcific Aortic Valve Disease , 2011, PloS one.

[51]  C. Semsarian,et al.  Rare non-synonymous variations in the transcriptional activation domains of GATA5 in bicuspid aortic valve disease. , 2012, Journal of molecular and cellular cardiology.

[52]  C. Ward.  Clinical significance of the bicuspid aortic valve , 2000, Heart.

[53]  M. Mattei,et al.  Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes , 1991, Nature.

[54]  R. Norris,et al.  Epicardially derived fibroblasts preferentially contribute to the parietal leaflets of the atrioventricular valves in the murine heart. , 2012, Developmental biology.

[55]  Wolfram Kress,et al.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.

[56]  V. Probst,et al.  Familial Aggregation of Calcific Aortic Valve Stenosis in the Western Part of France , 2006, Circulation.

[57]  H. Cavé,et al.  Mutations in the PTPN11 Gene The Spectrum of Cardiac Anomalies in Noonan Syndrome as a Result of , 2013 .

[58]  Jonathan A. Epstein,et al.  The multifaceted role of Notch in cardiac development and disease , 2008, Nature Reviews Genetics.

[59]  S. Siu,et al.  Bicuspid aortic valve disease. , 2010, Journal of the American College of Cardiology.

[60]  J. Hoffman,et al.  The incidence of congenital heart disease. , 2002, Journal of the American College of Cardiology.

[61]  J. Kilman,et al.  Evidence for progression from mild to severe mitral regurgitation in mitral valve prolapse. , 1986, The American journal of cardiology.

[62]  A. Kraja,et al.  Genome-Wide Linkage Mapping for Valve Calcification Susceptibility Loci in Hypertensive Sibships: The Hypertension Genetic Epidemiology Network Study , 2007, Hypertension.

[63]  M. Gimbrone,et al.  A role for Smad6 in development and homeostasis of the cardiovascular system , 2000, Nature Genetics.

[64]  I. Graef,et al.  A Field of Myocardial-Endocardial NFAT Signaling Underlies Heart Valve Morphogenesis , 2004, Cell.

[65]  Suzanne Schubbert,et al.  Deregulated Ras signaling in developmental disorders: new tricks for an old dog. , 2007, Current opinion in genetics & development.

[66]  A. Bisno,et al.  Mitral valve prolapse: multifactorial etiologies and variable prognosis. , 1986, American heart journal.

[67]  Frank McCormick,et al.  Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. , 2004, Genes & development.

[68]  T. Sundt,et al.  Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. , 2007, The Journal of thoracic and cardiovascular surgery.

[69]  Marc K. Halushka,et al.  Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome , 2006, Science.

[70]  K. Ikeda,et al.  Filamin Associates with Smads and Regulates Transforming Growth Factor-β Signaling* , 2001, The Journal of Biological Chemistry.

[71]  K. Yutzey,et al.  Transcriptional regulation of heart valve development and disease. , 2011, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[72]  A. Colige,et al.  Tgfβ-Smad and MAPK signaling mediate scleraxis and proteoglycan expression in heart valves. , 2013, Journal of molecular and cellular cardiology.

[73]  P. Wordsworth,et al.  Genetic segregation analysis of familial mitral valve prolapse shows no linkage to fibrillar collagen genes. , 1989, British heart journal.

[74]  K. McBride,et al.  Heredity of bicuspid aortic valve: is family screening indicated? , 2011, Heart.

[75]  J. Erdmann,et al.  Novel missense mutations (p.T596M and p.P1797H) in NOTCH1 in patients with bicuspid aortic valve. , 2006, Biochemical and biophysical research communications.

[76]  J. Epstein,et al.  Coordinating tissue interactions: Notch signaling in cardiac development and disease. , 2012, Developmental cell.

[77]  Lisa J. Martin,et al.  Bicuspid aortic valve is heritable. , 2004, Journal of the American College of Cardiology.

[78]  B. Horne,et al.  Evidence for a Heritable Component in Death Resulting From Aortic and Mitral Valve Diseases , 2004, Circulation.

[79]  K. Yutzey,et al.  ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[80]  D. Judge,et al.  TGF-β–dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome , 2004 .

[81]  S. Ben Redjeb,et al.  [Coagulase-negative staphylococcal endocarditis]. , 1987, La Tunisie medicale.

[82]  D. Judge,et al.  TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. , 2004, The Journal of clinical investigation.

[83]  C. Walsh,et al.  Developmental basis for filamin-A-associated myxomatous mitral valve disease. , 2012, Cardiovascular research.

[84]  Bernard Keavney,et al.  Mutations in the Sarcomere Gene MYH7 in Ebstein Anomaly , 2011, Circulation. Cardiovascular genetics.

[85]  V. Garg.  Growth of the Normal Human Heart , 2012 .

[86]  D. Arking,et al.  Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome , 2003, Nature Genetics.

[87]  R. Hinton,et al.  Extracellular Matrix Remodeling and Organization in Developing and Diseased Aortic Valves , 2006, Circulation research.

[88]  Victor R. Preedy,et al.  Handbook of growth and growth monitoring in health and disease , 2012 .

[89]  V. Kaartinen,et al.  Deficient Signaling via Alk2 (Acvr1) Leads to Bicuspid Aortic Valve Development , 2012, PloS one.

[90]  V. Probst,et al.  Filamin-A-Related Myxomatous Mitral Valve Dystrophy: Genetic, Echocardiographic and Functional Aspects , 2011, Journal of cardiovascular translational research.

[91]  T. N. Phillips,et al.  Coagulase-negative staphylococcal endocarditis. Occurrence in patients with mitral valve prolapse. , 1986 .

[92]  H. Cavé,et al.  The Spectrum of Cardiac Anomalies in Noonan Syndrome as a Result of Mutations in the PTPN11 Gene , 2007, Pediatrics.

[93]  C. Otto,et al.  The bicuspid aortic valve: adverse outcomes from infancy to old age. , 2005, Circulation.

[94]  Luis Vidali,et al.  Filamin A (FLNA) is required for cell–cell contact in vascular development and cardiac morphogenesis , 2006, Proceedings of the National Academy of Sciences.

[95]  Jonathan C. Cohen,et al.  GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5 , 2003, Nature.

[96]  R. Levine,et al.  Molecular genetics of mitral valve prolapse , 2007, Current opinion in cardiology.

[97]  B. Lilly,et al.  Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease. , 2013, Journal of molecular and cellular cardiology.

[98]  R A Levine,et al.  Prevalence and clinical outcome of mitral-valve prolapse. , 1999, The New England journal of medicine.

[99]  Mark D. Huffman,et al.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.

[100]  Kathleen F. Kerr,et al.  Genetic associations with valvular calcification and aortic stenosis. , 2013, The New England journal of medicine.

[101]  J. Le Heuzey,et al.  Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1. , 1999, American journal of human genetics.

[102]  R. Markwald,et al.  Bone morphogenetic protein-2 can mediate myocardial regulation of atrioventricular cushion mesenchymal cell formation in mice. , 2004, Developmental biology.

[103]  Ada Hamosh,et al.  Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene , 1991, Nature.